Volketswil near Zurich, Switzerland, June 25, 2014 – For the expansion of the board, Richard Fritschi is the ideal candidate, as he holds a certificate in economy and has spent most of his professional life in the field of medical technology. He was the President of Sulzer Orthopädie/Sulzermedica, Zimmer and previously CEO at Ypsomed. Since 2011, Fritschi is the Executive Director at Biodenta Corp., Taiwan and in the Board of Directors of several public and non-public companies. He is also a member of the Board of Management of the Medical Cluster organization.
With Richard Fritschi, Hocoma expands her Board of Directors to five members and strengthens her strategic positioning as world market leader. Dr. Gery Colombo, CEO of Hocoma and member of the Board of Directors: “We are very pleased to welcome such an international and convincing entrepreneur like Richard Fritschi to our Board of Directors. With his vast Sales experience in the B2C as well as in the B2B market and his profound knowledge in the Medtech industry, he is a valuable addition to our team and ideally complements the competencies of the other members.”
The new Hocoma Board of Directors consists of the following five members: Dr. rer. pol. Peter Hostettler, Founder and Chairman of the Board of Directors, Dr. sc. techn. Gery Colombo, Founder and CEO Hocoma AG, Dr. sc. techn. Ulrich Stüssi, Member of Boards of Directors, Dr. oec. HSG Urs Rickenbacher, Delegate of the Board, CEO of the Lantal Group in Langenthal, Richard Fritschi, Member of Board of Directors and Executive Director Biodenta Corp., Taiwan.
